TB-500

Description

Overview
TB‑500 is a synthetic fragment of thymosin beta‑4 supplied in lyophilised form for laboratory research use only. Preclinical literature discusses its relationship with actin‑binding dynamics, cytoskeletal organisation, and cell‑migration assay markers under controlled experimental conditions.

Research Context
– Investigated in vitro and in vivo models assessing peptide–protein interactions within cytoskeletal systems.
– Examined in assay configurations focusing on markers related to motility, angiogenic signalling, and tissue‑remodelling pathways.
– Findings are model‑specific and limited to defined research settings.

Format and Documentation
– Lyophilised peptide; nominal content per vial as labelled
– Certificate of Analysis (COA) provided for each lot
– Storage guidance for research environments on label/COA

Compliance
For laboratory research use only (RUO). Not for human or veterinary use, diagnostic or therapeutic applications.

FAQs
What is TB‑500 in research contexts?
A thymosin beta‑4 fragment used in studies of cytoskeletal dynamics and cell‑migration markers under controlled conditions.

Do you provide a COA?
Yes — each lot is supplied with a Certificate of Analysis.

How should it be stored in a lab?
Follow the label/COA storage guidance suitable for research environments.

Form: Lyophilised powder
Intended use: Laboratory research use only
Documentation: Certificate of Analysis where applicable
Dispatch: Fast UK fulfilment
Storage:
– Powder: -20°C 3 years ; 4°C 2 years ; 15°C 3 month
– In solvent: -80°C 6 months ; -2°C 1 month ; 10°C 1 week

Product disclaimer
This product is supplied strictly for laboratory research use only. Not for human or veterinary